Total number of projects: 8
As coordinator: 1
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0.14*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2012 | 0 | 2.454.604 | 246.384 | 1 | ||
2011 | 0 | 6.696.989 | 162.694 | 2 | ||
2010 | 2.996.324 | 18.336.112 | 2.509.374 | 1 | 4 |
Total number of partners: 1059
Partner loyalty:
Frequent Partner: (> 2 projects): 357
Rare Partner: 702
Frequent / Rare Partner Ratio: 0.51
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2012-08-01 | Quantitative Imaging of Liver Fibrosis and Fibrogenesis | LiverFibrosisImaging | participant | 2.454.604 | 3 |
2011-01-01 | Genetic testing in Europe - Network for the further development, harmonization, validation and standardization of services | EuroGentest2 | participant | 1.996.989 | 22 |
2011-01-01 | HEPATIC MICROFLUIDIC BIOREACTOR | HeMiBio | participant | 4.700.000 | 13 |
2010-12-01 | International Research on Quality in Healthcare | InterQuality | participant | 2.950.130 | 9 |
2010-11-01 | Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency | CELL-PID | participant | 11.887.735 | 20 |
2010-11-01 | Host and viral factors in acute hepatitis C | HepaCute | participant | 2.999.500 | 17 |
2010-09-01 | The impact of Regulation (EC) No 1394/2007 on the development of Advanced Therapy Medicinal Products (ATMPs): an academic perspective | Academic GMP | participant | 498.747 | 9 |
2010-01-01 | Neuroscience on Barriers in Development | NEUROBID | coordinator | 2.996.324 | 10 |